JA Bell

683 total citations
9 papers, 577 citations indexed

About

JA Bell is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, JA Bell has authored 9 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in JA Bell's work include HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). JA Bell is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). JA Bell collaborates with scholars based in United Kingdom. JA Bell's co-authors include Ian O. Ellis, CW Elston, P.M. Wencyk, RW Blamey, M Galea, JFR Robertson, R. Nicholson, RW Blamey, Robert I. Nicholson and S Pinder and has published in prestigious journals such as British Journal of Cancer, The Journal of Pathology and The Breast.

In The Last Decade

JA Bell

9 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JA Bell United Kingdom 7 370 250 184 128 107 9 577
H Goulding United Kingdom 5 194 0.5× 133 0.5× 185 1.0× 44 0.3× 32 0.3× 7 429
RW Blamey United Kingdom 13 715 1.9× 586 2.3× 244 1.3× 275 2.1× 210 2.0× 13 1.1k
Masahiro Ohara Japan 16 299 0.8× 209 0.8× 193 1.0× 75 0.6× 86 0.8× 44 654
J.L. Ostrowski United Kingdom 8 327 0.9× 183 0.7× 202 1.1× 86 0.7× 53 0.5× 8 479
RD Rubens United Kingdom 8 436 1.2× 421 1.7× 162 0.9× 63 0.5× 42 0.4× 9 691
AD Thor United States 2 456 1.2× 517 2.1× 203 1.1× 278 2.2× 116 1.1× 2 819
J Gest France 8 382 1.0× 177 0.7× 373 2.0× 101 0.8× 77 0.7× 20 722
Boriana Zaharieva Bulgaria 9 231 0.6× 165 0.7× 301 1.6× 46 0.4× 62 0.6× 21 575
Katherine Ory France 7 447 1.2× 146 0.6× 337 1.8× 84 0.7× 19 0.2× 9 700
Silvana Vignati Italy 7 184 0.5× 152 0.6× 257 1.4× 29 0.2× 41 0.4× 9 489

Countries citing papers authored by JA Bell

Since Specialization
Citations

This map shows the geographic impact of JA Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Bell more than expected).

Fields of papers citing papers by JA Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JA Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Bell. The network helps show where JA Bell may publish in the future.

Co-authorship network of co-authors of JA Bell

This figure shows the co-authorship network connecting the top 25 collaborators of JA Bell. A scholar is included among the top collaborators of JA Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JA Bell. JA Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Johnson, William, et al.. (2018). OP10 Worse baseline risk factors explain the association of healthy obesity with increased mortality risk: whitehall II study. Oral Presentations. A5.2–A5. 1 indexed citations
2.
Barnes, A., JA Bell, P.M. Wencyk, et al.. (2003). Expression of p27kip1 in breast cancer and its prognostic significance. The Journal of Pathology. 201(3). 451–459. 37 indexed citations
3.
Lambie, Hannah, S Pinder, JA Bell, et al.. (2003). Prognostic significance of BRCA1 expression in sporadic breast carcinomas. The Journal of Pathology. 200(2). 207–213. 48 indexed citations
4.
Pinder, S, JA Bell, P.M. Wencyk, et al.. (1996). C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. British Journal of Cancer. 74(2). 229–233. 106 indexed citations
5.
Goulding, H, Bharat Jasani, Ann Reid, et al.. (1995). Metallothionein expression in human breast cancer. British Journal of Cancer. 72(4). 968–972. 80 indexed citations
6.
Wencyk, P.M., JA Bell, CW Elston, et al.. (1995). Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. British Journal of Cancer. 71(1). 146–149. 156 indexed citations
7.
Snead, David, M Galea, JA Bell, et al.. (1993). Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. British Journal of Cancer. 68(1). 156–161. 59 indexed citations
8.
Galea, M, JA Bell, R. Nicholson, et al.. (1992). p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. British Journal of Cancer. 66(3). 583–588. 88 indexed citations
9.
Galea, M, et al.. (1992). Cathepsin D reactivity in human breast carcinoma. Important prognostic factor or epiphenomenon. The Breast. 1(3). 159–159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026